The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123370293 12337029 3 F 20150716 20160804 20160505 20160811 EXP PHHY2016FR056310 NOVARTIS 47.55 YR M Y 89.00000 KG 20160811 MD FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123370293 12337029 1 PS CERTICAN EVEROLIMUS 1 Oral 6 MG, QD 1620 MG 21560 6 MG QD
123370293 12337029 2 SS CERTICAN EVEROLIMUS 1 Oral 8 MG, QD 1620 MG 21560 8 MG QD
123370293 12337029 3 SS CERTICAN EVEROLIMUS 1 Oral 7 MG, QD 1620 MG 21560 7 MG QD
123370293 12337029 4 SS CERTICAN EVEROLIMUS 1 Oral 4 MG, QD 1620 MG 21560 4 MG QD
123370293 12337029 5 SS CERTICAN EVEROLIMUS 1 Oral 2 MG, QD 1620 MG 21560 2 MG QD
123370293 12337029 6 SS CERTICAN EVEROLIMUS 1 Oral 4 MG, QD 1620 MG 21560 4 MG QD
123370293 12337029 7 SS CERTICAN EVEROLIMUS 1 Oral 5 MG, QD 1620 MG 21560 5 MG QD
123370293 12337029 8 SS MYFORTIC MYCOPHENOLATE SODIUM 1 Oral 1440 MG, QD 0 1440 MG QD
123370293 12337029 9 SS MYFORTIC MYCOPHENOLATE SODIUM 1 0
123370293 12337029 10 C CORTANCYL PREDNISONE 1 Unknown 1 MG, QD 31 MG 0 1 MG QD
123370293 12337029 11 C PROGRAF TACROLIMUSTACROLIMUS ANHYDROUS 1 Unknown 4 MG, QD Y 0 4 MG QD
123370293 12337029 12 C PROGRAF TACROLIMUSTACROLIMUS ANHYDROUS 1 Oral 3 MG, QD Y 0 3 MG QD
123370293 12337029 13 C PROGRAF TACROLIMUSTACROLIMUS ANHYDROUS 1 Unknown 1.5 MG, QD Y 0 1.5 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123370293 12337029 1 Liver transplant
123370293 12337029 2 Immunosuppressant drug therapy
123370293 12337029 8 Liver transplant
123370293 12337029 9 Immunosuppressant drug therapy
123370293 12337029 10 Immunosuppressant drug therapy
123370293 12337029 11 Immunosuppressant drug therapy

Outcome of event

Event ID CASEID OUTC COD
123370293 12337029 HO
123370293 12337029 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
123370293 12337029 Abdominal hernia
123370293 12337029 Abscess
123370293 12337029 Hypercholesterolaemia
123370293 12337029 Impaired healing
123370293 12337029 Purulent discharge
123370293 12337029 Pyrexia
123370293 12337029 Scar

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123370293 12337029 1 20140124 20141020 0
123370293 12337029 2 20141021 20150218 0
123370293 12337029 3 20150219 20150603 0
123370293 12337029 4 20150604 20160302 0
123370293 12337029 5 20160303 20160407 0
123370293 12337029 6 20160607 20160711 0
123370293 12337029 7 20160712 0
123370293 12337029 8 20131117 0
123370293 12337029 10 20140417 20140517 0
123370293 12337029 11 20160303 20160406 0
123370293 12337029 12 20160407 20160606 0
123370293 12337029 13 20160607 20160712 0